Source: Lab Bulletin

SeraCare: LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

LGC SeraCare is pleased to announce that the AccuPlex SARS-CoV-2 Reference Material Kit v2 is now CE-marked for in vitro diagnostic use (CE-IVD). With this change in regulatory status, the new product name is AccuPlex SARS-CoV-2 Molecular Controls Kit. Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements....

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael Sweatt's photo - General Manager of SeraCare

General Manager

Michael Sweatt

CEO Approval Rating

82/100

Read more